Kayitalire Louis 4
4 · F-star Therapeutics, Inc. · Filed Nov 4, 2021
Insider Transaction Report
Form 4
Kayitalire Louis
Chief Medical Officer
Transactions
- Sale
Common Stock
2021-11-02$6.81/sh−39$266→ 54,280 total - Sale
Common Stock
2021-11-02$6.85/sh−25$171→ 54,255 total
Footnotes (2)
- [F1]Shares sold pursuant to the 10b5-1 Plan entered into by the Reporting Person.
- [F2]Includes 45,443 restricted stock units.